Crohn's disease
Not recruitingStudy on Guselkumab for Healing in Crohn's Disease Patients
- Disease:Crohn's disease
- Substances:Guselkumab
France- Participants:18–64 years · 65+ years
- Substances:Guselkumab
- Sponsor:Janssen Cilag International
Rare diseases
Investigational molecules
Locations
Back to France1 327 clinical trials in Lille, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma, exploring novel treatment combinations and targeted therapies. Additional research includes investigations into pancreatic cancer and gastric cancer treatments.
Studies are evaluating innovative therapeutic agents and their effectiveness in treating various forms of cancer.
Comprehensive research into Alzheimer's disease and Amyotrophic Lateral Sclerosis, examining new treatment approaches and disease mechanisms. Studies also include investigations of essential tremor treatments.
Research focuses on understanding disease progression and developing targeted interventions.
Innovative trials examining treatments for Crohn's disease and Multiple Sclerosis. Research includes novel approaches to managing chronic inflammatory conditions and immune system disorders.
Studies aim to improve treatment outcomes and develop more effective therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.